Home > Cashflow Statement > MANKIND PHARMA

MANKIND PHARMA
Cashflow Statement

MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
AD     Remove this Ad

MANKIND PHARMA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹2,525 Cr₹2,399 Cr₹1,671 Cr₹1,975 Cr₹1,692 Cr
Adjustment ₹602 Cr₹212 Cr₹298 Cr₹31 Cr₹-5.66 Cr
Changes In working Capital ₹-146 Cr₹-18 Cr₹167 Cr₹-586 Cr₹-95 Cr
Cash Flow after changes in Working Capital ₹2,980 Cr₹2,594 Cr₹2,136 Cr₹1,419 Cr₹1,591 Cr
Cash Flow from Operating Activities ₹2,413 Cr₹2,152 Cr₹1,813 Cr₹920 Cr₹1,137 Cr
Cash Flow from Investing Activities ₹-12,683 Cr₹-2,082 Cr₹-1,054 Cr₹-1,369 Cr₹-1,222 Cr
Cash Flow from Financing Activities ₹10,233 Cr₹5.27 Cr₹-740 Cr₹605 Cr₹-7.81 Cr
Net Cash Inflow / Outflow ₹-37 Cr₹76 Cr₹19 Cr₹155 Cr₹-93 Cr
Opening Cash & Cash Equivalents ₹382 Cr₹305 Cr₹283 Cr₹127 Cr₹220 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger ₹-9.40 Cr----
Cash & Cash Equivalent of Subsidiaries under liquidations ₹67 Cr----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹1.31 Cr₹1.17 Cr₹2.32 Cr₹0.48 Cr₹0.38 Cr
Closing Cash & Cash Equivalent ₹404 Cr₹382 Cr₹305 Cr₹283 Cr₹127 Cr

Compare Cashflow Statement of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹82,454.7 Cr -1.1% -11.1% -16.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

-1.1%

-11.1%

-16.9%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses